AMB HK Enterprises Inc. Pharmaceutical Import Profile — Philippines (DGFT 2022–2026)

Name: AMB HK Enterprises Inc. Pharmaceutical Import Records from India — 5 Products, $6.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

AMB HK Enterprises Inc. — Pharmaceutical Importer Profile (2026) | 5 Products, $6.9M Trade | TransData Nexus

AMB HK Enterprises Inc.

Pharmaceutical Importer · Philippines · Diabetes & Endocrine Focus · $6.9M Total Trade · DGFT Verified

AMB HK Enterprises Inc. is a pharmaceutical importer based in Philippines with a total trade value of $6.9M across 5 products in 5 therapeutic categories. Based on 154 verified import shipments from Indian Customs (DGFT) records, AMB HK Enterprises Inc. is the #1 buyer in 1 product including Iodex. AMB HK Enterprises Inc. sources from 7 verified Indian suppliers, with Fredun Pharmaceuticals Limited accounting for 69.4% of imports.

AMB HK Enterprises Inc. — Import Portfolio & Supplier Network

AMB HK Enterprises Inc. import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to AMB HK Enterprises Inc.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Fredun Pharmaceuticals Limited	$12.2M	705	69.4%
Globela Pharma Private Limited	$3.3M	193	19.0%
Giyaan Pharma Private Limited	$898.1K

What Formulations Does AMB HK Enterprises Inc. Import?

Formulation	Value	Ships
Meoxiclav-ds co-amoxiclav [457MG/5ML	$750.0K	15
Ketorex (Pack 10x10's) (ketoanalogue	$544.1K	11
Pharmaceuticals products - ceticit	$303.3K	10
Pharmaceuticals products : ceticit cetirizine (10MG film coated tablet )	$293.2K	6
Pharmaceuticals products - citifar	$266.7K	6
Pharmaceuticals products - emicox 400	$221.6K	6
Pharmaceuticals products : citcole	$200.0K	4
Pharmaceuticals products - rozatin 20	$200.0K	4
Montephil-l (3x10's) (montelukast and	$183.8K	4
Pharmaceuticals products, ceticit cetirizine (10MG film coated tablet )	$182.3K	9
Pharmaceuticals products- fredtor-20	$171.9K	6
Pharmaceuticals products : ceticit cetirizine (10MG film coated tablet)	$168.2K	13
Pharmaceuticals products : lumareal	$150.0K	3
Copide (Pack 10x10's) (clopidogrel	$145.5K	5
Catania dapagliflozin (as propanediol monohydrate) 10MG Film-Coated	$137.3K	3

AMB HK Enterprises Inc. imports 522 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Sitagliptin	Diabetes & Endocrine	$3.3M	66	2.1%	6
2	Cetirizine	Antihistamines & Allergy	$2.0M	52	1.1%	19
3	Simvastatin	Cardiovascular	$700.0K	14	0.6%	4
4	Iodex	Brand Names & OTC Products	$609.9K	15	8.3%	1
5	Tramadol	Analgesics & Antipyretics	$350.0K	7	0.1%	5

AMB HK Enterprises Inc. imports 5 pharmaceutical products across 5 categories into Philippines totaling $6.9M. The company is the #1 buyer for 1 product: Iodex.

AMB HK Enterprises Inc. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

AMB HK Enterprises Inc. is a prominent pharmaceutical importer and distributor based in Pasig City, Metro Manila, Philippines. Established over a decade ago, the company specializes in the importation and distribution of high-quality medicines, medical devices, medical supplies, and veterinary products. With a strong network of manufacturing partnerships spanning China, India, Europe, and other regions, AMB HK Enterprises Inc. caters to the growing demand for affordable and effective healthcare solutions across the Philippines.

The company operates under the AMB-HK Group of Companies, which includes affiliates such as PhilRx Pharma Inc. and P&D Medivet Distribution Inc. These subsidiaries enable AMB HK Enterprises Inc. to offer a comprehensive range of products and services, addressing various sectors within the healthcare industry. Their mission is to enhance the health and wellness of consumers by providing innovative and high-quality products, while upholding values of integrity, synergy, commitment, excellence, and innovation.

2Distribution Network

AMB HK Enterprises Inc. maintains a centralized distribution hub at their headquarters in Pasig City, Metro Manila. This strategic location facilitates efficient logistics and timely delivery of pharmaceutical products throughout the Philippines. While specific details about additional warehouse locations are not publicly disclosed, the company's extensive network of regional and national distributors ensures comprehensive coverage across all 82 provinces in the country. This robust distribution framework enables AMB HK Enterprises Inc. to meet the diverse healthcare needs of both urban and rural populations.

3Industry Role

AMB HK Enterprises Inc. plays a pivotal role in the Philippines' pharmaceutical supply chain as a primary wholesaler and importer. By sourcing a wide array of pharmaceutical products from international manufacturers, the company ensures a steady supply of essential medicines and medical supplies to various healthcare providers, including hospitals, clinics, pharmacies, and veterinary institutions. Their commitment to quality and affordability positions them as a key player in enhancing the accessibility of healthcare products nationwide.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — AMB HK Enterprises Inc.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

AMB HK Enterprises Inc. demonstrates a strategic sourcing approach with a diversified supplier base, primarily from India. Between 2022 and 2026, the company imported finished pharmaceutical formulations totaling $6.9 million USD across 154 shipments, encompassing 522 unique formulations. The top five products imported include Sitagliptin ($3.3M), Cetirizine ($2.0M), Simvastatin ($700K), Iodex ($610K), and Tramadol ($350K), collectively accounting for 100% of their import portfolio. This concentration indicates a focused product strategy, potentially leveraging economies of scale and supplier relationships. However, the heavy reliance on a limited number of products may expose the company to market fluctuations and supply chain disruptions. Diversifying the product range could mitigate such risks and enhance resilience.

2Supply Chain Resilience

The resilience of AMB HK Enterprises Inc.'s supply chain is bolstered by its partnerships with multiple Indian suppliers, including Fredun Pharmaceuticals Limited, Globela Pharma Private Limited, and others. This multi-supplier strategy provides a buffer against potential disruptions from any single source. The company's importation of 522 unique formulations further demonstrates a diversified product portfolio, reducing dependency on specific products. While the exact shipping routes and backup suppliers are not publicly detailed, the established relationships with various manufacturers suggest a proactive approach to supply chain management. Ensuring that all suppliers adhere to Good Manufacturing Practice (GMP) standards is crucial for maintaining product quality and regulatory compliance.

Importing Pharmaceuticals into Philippines — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Philippines

1Regulatory Authority & Framework

In the Philippines, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation, distribution, and marketing of pharmaceutical products. The FDA ensures that all pharmaceutical products meet safety, efficacy, and quality standards before they are made available to the public. Key legislation governing pharmaceutical imports includes the Food, Drug, and Cosmetic Act (Republic Act No. 3720) and its subsequent amendments, which provide the legal framework for the regulation of drugs and devices. The marketing authorization pathway for Indian generics involves obtaining a Certificate of Product Registration (CPR) from the FDA, which requires submission of comprehensive documentation, including clinical trial data, manufacturing details, and labeling information. This rigorous process ensures that imported generics are equivalent in quality and efficacy to their branded counterparts.

2Import Licensing & GMP

Import licensing in the Philippines is mandatory for pharmaceutical products. Importers must secure an Import License from the FDA, which involves demonstrating compliance with regulatory requirements and maintaining proper documentation. Good Manufacturing Practice (GMP) certification is a critical component of this process. The FDA recognizes GMP certificates from reputable authorities, including the World Health Organization (WHO), the European Union (EU), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian exporters seeking to supply AMB HK Enterprises Inc. must ensure that their manufacturing facilities hold valid GMP certifications from these recognized bodies. Additionally, obtaining wholesale distribution authorization from the FDA is essential for legal distribution within the Philippines.

AMB HK Enterprises Inc. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

AMB HK Enterprises Inc.'s focus on importing products in the therapeutic areas of diabetes, antihistamines, and cardiovascular treatments aligns with the prevalent health concerns in the Philippines. The high incidence of diabetes and cardiovascular diseases in the country drives substantial demand for effective treatments. By concentrating on these areas, the company addresses critical healthcare needs and positions itself as a key supplier of essential medications. The inclusion of antihistamines caters to the widespread prevalence of allergic conditions, further broadening their market reach.

2Sourcing Profile

AMB HK Enterprises Inc. employs a sourcing strategy that emphasizes the importation of generic drugs, particularly those manufactured in India. This approach allows the company to offer cost-effective alternatives to branded medications without compromising on quality. The preference for finished pharmaceutical formulations, such as tablets, capsules, syrups, and injections, indicates a focus on ready-to-market products that meet the immediate needs of healthcare providers. India's robust pharmaceutical manufacturing sector, with its adherence to international GMP standards, makes it a reliable source for these formulations.

3Market Positioning

Seller's Guide — How to Become a Supplier to AMB HK Enterprises Inc.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with AMB HK Enterprises Inc., especially in the therapeutic areas of diabetes, antihistamines, and cardiovascular treatments. The company's concentrated product portfolio suggests potential gaps in certain segments, such as oncology or respiratory drugs, where additional suppliers could provide value. Establishing partnerships with AMB HK Enterprises Inc. would require ensuring compliance with FDA regulations, obtaining necessary certifications, and aligning with the company's quality standards.

2Requirements & Qualifications

Indian exporters aiming to supply AMB HK Enterprises Inc. must ensure that their manufacturing facilities hold valid GMP certifications from recognized authorities, including WHO, EU GMP, or PIC/S. Additionally, obtaining an Import License from the Philippines FDA is mandatory for legal distribution within the country

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — AMB HK Enterprises Inc.

What products does AMB HK Enterprises Inc. import from India?

AMB HK Enterprises Inc. imports 5 pharmaceutical products across 5 categories. Top imports: Sitagliptin ($3.3M), Cetirizine ($2.0M), Simvastatin ($700.0K), Iodex ($609.9K), Tramadol ($350.0K).

Who supplies pharmaceuticals to AMB HK Enterprises Inc. from India?

AMB HK Enterprises Inc. sources from 7 verified Indian suppliers. The primary supplier is Fredun Pharmaceuticals Limited (69.4% of imports, $12.2M).

What is AMB HK Enterprises Inc.'s total pharmaceutical import value?

AMB HK Enterprises Inc.'s total pharmaceutical import value from India is $6.9M, based on 154 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does AMB HK Enterprises Inc. focus on?

AMB HK Enterprises Inc. imports across 5 categories. The largest: Diabetes & Endocrine (47.6%), Antihistamines & Allergy (28.5%), Cardiovascular (10.1%).

Get Full AMB HK Enterprises Inc. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.